• What is Chemokine Therapeutics' business?
  
• When was Chemokine Initial Public Offering (IPO)? And what was the price?
  
• On what Stock Exchange is Chemokine traded on? And what is the symbol?
  
• When is your Annual General Meeting of shareholders?
  
• Who is Chemokine's Transfer Agent?
  
• I have lost my stock certificates, how can I replace them?
  
• Does Chemokine pay dividends on shares?
  
• How can I obtain a copy of Chemokine's most recent Annual Report?
  
• When are Chemokine's fiscal quarter and year-end dates, and what are the corresponding dates for release of results?
  

What is Chemokine Therapeutics' business?
Chemokine Therapeutics is a product-focused biotechnology company developing drugs that harness the therapeutic potential of stem cells through Chemokine pathways.

When was Chemokine Therapeutics Initial Public Offering (IPO)? And what was the price?
Chemokine went public on December 31, 2004 and started trading at $1.00 CDN a share.

On what Stock Exchange is Chemokine Therapeutics traded on? And what is the symbol?
Chemokine is currently trading on two stock exchange markets; the Toronto Stock Exchange (TSX) under the ticket symbol 'CTI', and on the Over The Counter Bulletin Board (OTC BB), under the ticket symbol 'CHKT'.

When is your Annual General Meeting of Shareholders?
To be determined.

Who is Chemokine Therapeutics' Transfer Agent?
Computer Share Trust Company
800-350 Indiana Street
Golden, CO
80401 USA
Tel: (303) 262-0889
Fax: (303) 262-0632

I have lost my stock certificates, how can I replace them?
Please contact our Transfer Agent, Computer Share Trust Company, at (303) 262-0889

Does Chemokine Therapeutics pay dividends on shares?
Not at this time.

How can I obtain a copy of Chemokine Therapeutics' most recent Annual Report?
Our Annual Report is available here.

When are Chemokine's fiscal quarter and year-end dates, and what are the corresponding dates for release of results?
Chemokine operates on a fiscal year ending December 31. Our quarterly reporting periods end on March 31, June 30, September 30, December 31. Quarterly results and corresponding news releases are issued approximately six weeks after the end of the reporting period.